1. Home
  2. RMM vs CCCC Comparison

RMM vs CCCC Comparison

Compare RMM & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMM
  • CCCC
  • Stock Information
  • Founded
  • RMM 2019
  • CCCC 2015
  • Country
  • RMM United States
  • CCCC United States
  • Employees
  • RMM N/A
  • CCCC N/A
  • Industry
  • RMM Trusts Except Educational Religious and Charitable
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMM Finance
  • CCCC Health Care
  • Exchange
  • RMM Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • RMM 302.6M
  • CCCC 304.8M
  • IPO Year
  • RMM N/A
  • CCCC 2020
  • Fundamental
  • Price
  • RMM $15.17
  • CCCC $6.25
  • Analyst Decision
  • RMM
  • CCCC Buy
  • Analyst Count
  • RMM 0
  • CCCC 7
  • Target Price
  • RMM N/A
  • CCCC $8.71
  • AVG Volume (30 Days)
  • RMM 66.5K
  • CCCC 2.5M
  • Earning Date
  • RMM 01-01-0001
  • CCCC 08-06-2024
  • Dividend Yield
  • RMM 7.33%
  • CCCC N/A
  • EPS Growth
  • RMM N/A
  • CCCC N/A
  • EPS
  • RMM 0.96
  • CCCC N/A
  • Revenue
  • RMM N/A
  • CCCC $20,036,000.00
  • Revenue This Year
  • RMM N/A
  • CCCC $26.24
  • Revenue Next Year
  • RMM N/A
  • CCCC N/A
  • P/E Ratio
  • RMM $15.55
  • CCCC N/A
  • Revenue Growth
  • RMM N/A
  • CCCC N/A
  • 52 Week Low
  • RMM $12.32
  • CCCC $1.06
  • 52 Week High
  • RMM $16.10
  • CCCC $11.88
  • Technical
  • Relative Strength Index (RSI)
  • RMM 48.52
  • CCCC 60.64
  • Support Level
  • RMM $15.21
  • CCCC $4.36
  • Resistance Level
  • RMM $15.50
  • CCCC $7.66
  • Average True Range (ATR)
  • RMM 0.19
  • CCCC 0.56
  • MACD
  • RMM -0.03
  • CCCC 0.27
  • Stochastic Oscillator
  • RMM 12.88
  • CCCC 57.34

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: